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Abstract
The structure of the complex between cytochrome c (CYC) and the cytochrome bc1 complex (QCR) from yeast crystallized with an
antibody fragment has been recently determined at 2.97 A˚ resolution [Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 2800]. CYC binds to subunit
cytochrome c1 of the enzyme stabilized by hydrophobic interactions surrounding the heme crevices creating a small, compact contact site. A
central cation-k interaction is an important and conserved feature of CYC binding. Peripheral patches with highly conserved complementary
charges further stabilize the enzyme–substrate complex by long-range electrostatic forces and may affect the orientation of the substrate. Size
and characteristics of the contact site are optimal for a transient electron transfer complex. Kinetic data show a bell-shaped ionic strength
dependence of the cytochrome c reduction with a maximum activity near physiological ionic strength. The dependence is less pronounced in
yeast compared to horse heart CYC indicating less impact of electrostatic interactions in the yeast system. Interestingly, a local QCR activity
minimum is found for both substrates at 120–140 mM ionic strength. The architecture of the complex results in close distance of both c-type
heme groups allowing the rapid reduction of cytochrome c by QCR via direct heme-to-heme electron transfer. Remarkably, CYC binds only
to one of the two possible binding sites of the homodimeric complex and binding appears to be coordinated with the presence of ubiquinone
at the Qi site. Regulatory aspects of CYC reduction are discussed.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Small diffusible redox proteins facilitate electron trans-
port between large membrane-embedded enzyme complexes
in cell respiration and photosynthesis. To promote high
turnover and efficiency of the energy converting machinery,
binding of the mobile electron carrier proteins has to be both
transient and specific.
In mitochondrial respiration cytochrome c (CYC), a
small water-soluble protein that has a covalently attached
heme c group, shuttles electrons between ubiquinol:cyto-
chrome c oxidoreductase (QCR, cytochrome bc1 complex)
and cytochrome c oxidase (COX) in the intermembrane
space [2]. QCR (E.C. 1.20.2.2) is a multisubunit, integral
membrane protein complex, which passes electrons from
ubiquinol to CYC and couples this process to translocation
of protons across the inner mitochondrial membrane as
described by the Q cycle [3–5].
QH2 þ 2CYCðFe3þÞ þ 2Hþi ! Qþ 2CYCðFe2þÞ þ 4Hþo
Each monomer of the homodimeric complex contains
three essential catalytic subunits with prosthetic groups:
cytochrome b (COB) with two b-type heme groups, cyto-
chrome c1 (CYT1) with a c-type heme, and the Rieske protein
(RIP1) containing an [2Fe–2S] iron–sulfur cluster. Mito-
chondrial QCRs contain up to eight additional subunits [6].
The Q cycle involves separate catalytic sites for quinol
oxidation (Qo site) and quinone reduction (Qi site). Protons
are taken up from the matrix side while quinone is reduced
to quinol and protons are released to the intermembrane side
upon quinol oxidation. Ubiquinol oxidation at the Qo site
involves a bifurcated electron transfer. One electron is
transferred via the [2Fe–2S] cluster to heme c1, the electron
donor for CYC reduction. The second electron is passed via
heme bL and heme bH to the Qi site and reduces quinone to
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semiquinone and after a second round of the cycle to quinol.
X-ray structures have been reported for mitochondrial QCRs
from beef and chicken [7–9] and for the complex from the
yeast Saccharomyces cerevisiae [10] and led to major
progress in understanding the enzyme mechanism and
structure–function relationships. Remarkably, the X-ray
structures identified that the extrinsic catalytic domain of
RIP1 is mobile [8]. An alternating movement between the
redox-center domains of COB (b-position) and CYT1 (c-
position) may facilitate the bifurcation of the electron trans-
fer pathway at the Qo site [8,11,12].
Despite detailed information about the catalytic mecha-
nism, the binding of CYC to QCR has been debated [13].
The proper encounter complex between CYC and QCR is
critical for ubiquinol oxidation and full turnover of QCR.
Complex formation has to be fast and specific to achieve an
orientation of the reaction partners suitable for fast electron
transfer followed by fast dissociation of the product com-
plex. Structures of transient redox complexes are difficult to
obtain and only few have been determined by X-ray
diffraction or NMR spectroscopy [14–16]. In the past,
CYC binding to QCR was thought to be dominated by
electrostatic interactions, as an increase in ionic strength
slowed down CYC reduction [17,18]. Chemical labeling
studies, mutagenesis and cross-linking experiments concen-
trated on analysis of charged residues. A ring of conserved
lysine residues surrounding the heme cleft of CYC and
negatively charged residues of subunit CYT1 of QCR were
identified to be involved in CYC binding [19–21]. How-
ever, the first X-ray structural study of such a complex,
namely the complex between CYC and the soluble cyto-
chrome c peroxidase (CCP) from yeast [14], elucidated the
considerable contribution of hydrophobic forces to the
binding interaction.
Recently, the crystal structure of the enzyme–substrate
complex between cytochrome bc1 complex and cyto-
chrome c was published [1]. This is, to our knowledge,
the first structure of a redox complex between a membrane
protein and a small diffusible carrier. Here, we discuss
crystallization conditions and highlight insights from the
structure of the complex with respect to the enzyme
mechanism.
2. Methods
Yeast QCR was purified as previously described [10,22].
Yeast iso-1-CYC was purchased from Sigma. For determi-
nation of QCR activity at different ionic strengths, iso-1-
CYC was purified by cation exchange chromatography, as
the latter has been shown to separate iso-2-CYC [23]. In
short, yeast CYC was applied to a cation exchange column
(20 ml Biorex 70, Bio-Rad Laboratories) equilibrated with
50 mM Hepes 7.0, 50 mM NaCl. Isoforms were eluted
using a 100–500 mM NaCl gradient in the same buffer over
10 column volumes. Iso-2-CYC elutes at higher salt con-
centrations than iso-1-CYC and was successfully removed.
Both isoforms were verified by N-terminal sequencing.
CYC-affinity matrix was prepared by covalently cou-
pling iso-1-CYC via its freely accessible C-terminal cys-
teine residue (Cys108) to SH-sepharose. Iso-1-CYC (25 mg)
was immobilized to 8 ml of the swollen matrix as described
in Ref. [24]. For the final affinity matrix, a CYC concen-
tration of 178 AM was estimated by spectroscopic quanti-
fication of CYC after extraction from a matrix aliquot with
h-mercaptoethanol.
Binding experiments were carried out using 50 Al affinity
matrix mixed with 0.38 nmol of purified QCR in 100 Al
buffer with different ionic strengths [40 mM Tris, pH 7.4,
0.05% undecyl-h-maltopyranoside (UM), NaCl concentra-
tion varied]. After incubation for 20 min, the mixture was
loaded into small column holders, unbound QCR removed
by washing with 100 Al followed by 600 Al of the same
buffer and eluted by addition of 100 Al high salt buffer (500
mM NaCl in the same buffer). Experiments were carried out
at 4 jC and room temperature.
For elution experiments, pure QCR samples were bound
to 0.5 ml column matrix at an ionic strength of 40 mM.
QCR elution in steps of 1 ml aliquots of buffer with
increasing ionic strength was monitored at 415 nm in the
eluate fractions.
Enzyme activity was determined by following the reduc-
tion of CYC by QCR with a spectrophotometric assay at
550 nm as previously described [23], but with minor
modifications. Decylubiquinol (80 AM) and CYC (50 AM)
(purified iso-1-CYC or horse heart CYC) were incubated in
assay buffer (40 mM Tris/HCl pH 7.4, 0.05%, variable
concentrations of NaCl) at 25 jC. The reaction was started
by the addition of QCR to a final concentration of 0.625 nM
and followed for 3 min at 550 nm. The reduction rate was
calculated from the initial linear slope after subtracting the
non-enzymatic background.
QCR was quantified by redox absorption spectra using an
extinction coefficient of 28.5 mM  1 cm  1 (563–577 nm,
dithionite-reduced minus ferricyanide-oxidized) [25].
Ionic strength of buffers containing Tris/HCl was calcu-
lated with the simplifying assumption of fully dissociated
buffer molecules.
Amino acid residues of all subunits of yeast QCR, as
well as of yeast CYC, are numbered according to the initial
translation product.
3. Crystallization of the QCR:CYC complex and
structure determination
For crystallization of the yeast QCR:CYC complex, two
major problems had to be overcome. First, protein proper-
ties and conditions of the solution that favor complex
formation had to be found. Second, crystallization was
challenged with one of the components being an integral
membrane protein complex. The latter was addressed by
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antibody fragment mediated crystallization, a technique that
improves the chances of obtaining well-ordered crystals of a
membrane protein by enlarging the polar, solvent exposed
surface important for formation of stable crystal contacts
[11,26,27]. The antibody fragment FV18E11 derived from the
parental antibody mAB18E11 binds to the extrinsic domain of
subunit RIP1 and is essential for crystallization of yeast
QCR [10,11]. The bound FV fragment does not affect the
enzyme activity (unpublished results) and, therefore, should
not interfere with enzyme–substrate complex formation.
High purity of yeast QCR and FV fragment preparations,
as well as the stability of their binding has already been
demonstrated by successful crystallization and structure
determination of yeast QCR [10]. Furthermore, binding of
the antibody fragment provides a spacious crystal packing,
in which CYC could, in principle, bind to subunit CYT1 of
QCR. Therefore, the yeast QCR:FV18E11 complex was used
as binding partner for CYC.
Optimal binding conditions for CYC and QCR were
deduced from CYC affinity chromatography experiments
(Fig. 1a,b). A series of purified yeast QCR samples with
different ionic strengths were prepared and loaded onto
CYC affinity columns (Fig. 1a). At room temperature,
binding of QCR is high at 80, 100 and 120 mM ionic
strength, lower at 140 and 160 mM, and drastically
decreased above 160 mM ionic strength. At 4 jC, the
amount of bound QCR is lower and binding is only
achieved at ionic strengths of 160 mM or below. Also,
QCR was bound to the affinity matrix at low ionic strength
and eluted stepwise with increasing concentrations of NaCl.
At 4 jC, elution of QCR starts at 120 mM and is entirely
eluted from the matrix at 130 mM ionic strength (Fig. 1b).
The lower ionic strength limit for QCR binding in the
elution assay might be caused by a lower QCR to CYC
ratio and a higher dilution of the protein during elution.
A bell-shaped ionic strength dependence of yeast QCR
activity has been previously shown [28]. This analysis
covered a wide range of ionic strengths, whereas we were
interested in identifying differences within the physiological
limits to optimize complex formation. QCR activity at
different ionic strengths were tested using purified yeast
QCR and purified iso-1-CYC. From 40 to 120 mM, the
turnover number increases from 75 to 102 s 1. Interest-
ingly, a local minimum is observed at 140 mM. The primary
structure of CYC is highly conserved in evolution [29] and
horse CYC is often used as substrate in yeast QCR activity
assays. Remarkably, bell-shaped ionic strength dependence
is more pronounced for horse CYC compared to yeast CYC.
Turnover numbers decrease below 60 mM and above 160
mM, the highest activity is found at 80 mM. Furthermore,
the local activity minimum at medium ionic strength (120–
140 mM) is more pronounced.
Fig. 1. (a) Ionic strength dependent binding of yeast QCR to immobilized
yeast iso-1-CYC. Pure QCR samples were bound to the affinity matrix at
varying ionic strength. Unbound material was washed off, and bound QCR
was quantified at 413 nm in one-step eluates at high salt concentration. In
general, binding is higher at 4 jC (black bars) compared to room
temperature (gray bars). Best binding occurs below 160 mM ionic strength.
(b) Ionic strength dependent elution of yeast QCR bound to immobilized
yeast iso-1-CYC. QCR was bound to the affinity matrix at low salt
concentration and eluted stepwise with increasing ionic strength at 4 jC.
QCR was quantified at 415 nm in the respective eluates. QCR begins to
elute at an ionic strength of 120 mM and elutes nearly entirely at 130 mM.
(c) Bell-shaped dependence of QCR activity from ionic strength. Higher
activities are obtained using yeast iso-1-CYC (black triangles) compared to
horse heart CYC (open circles). Remarkably, a local activity minimum at
120–140 mM was found for both substrates.
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Bell-shaped ionic strength dependence of enzyme activ-
ity with an optimum at moderate ionic strength is character-
istic for proteins that form stable redox-complexes [30].
This has been described, for instance, for cytochrome f and
plastocyanin [31]. At low ionic strength, the low activity
could be explained by stronger electrostatic stabilization of
the complex, which might not be optimal for electron
transfer. Intermediate ionic strength may weaken these
interactions and allow rearrangement to a more productive
complex. High ionic strength disrupts stabilizing electro-
static interactions. The less pronounced dependence for
yeast CYC may indicate, that a smaller portion of the
stabilizing interactions are of electrostatic nature and that
little rearrangement occurs at low ionic strength. The very
reproducible local minima at 120–140 mM ionic strength,
i.e. in the physiological range, point to subtle differences in
complex formation and will be analyzed in future studies.
Based on these results, QCR:FV complex and CYC were
mixed at an ionic strength of 120 mM. Addition of precip-
itant solution decreases the initial ionic strength in the
crystallization drop to approximately 90 mM. Nuclei for-
mation and crystal growth start immediately. The final ionic
strength in the mother liquor of the crystal will be slightly
higher due to the vapor diffusion set-up. This condition
favors CYC binding, allows for high QCR activity and is, in
addition, in the range of the proposed physiological ionic
strength of the mitochondrial intermembrane space [13].
Although vapor diffusion set-ups are used for crystalli-
zation, crystal growth is very fast and often crystals can be
seen within 20 min. Nucleation is difficult to control
resulting in several hundred small crystals and only few
that are suitable for X-ray data collection (Fig. 2). Although
these crystals diffract X-rays at synchrotron sources to a
resolution better than 2.4 A˚, data collection can only be
performed at 4 jC up to now. Therefore, large crystals are
needed to obtain high resolution data sets. The structure was
determined at 2.97 A˚ resolution using a data set collected at
4 jC from a single crystal at beamline ID14EH3 (ESRF).
The structure was solved by molecular replacement [1]. The
dimeric QCR:FV fragment complex is present in the asym-
metric unit. 2Fo–Fc electron density maps after rigid body
refinement and energy minimization of the complex clearly
revealed the presence of a single CYC molecule bound to
one QCR monomer (monomer B). Distinct electron density
allowed the unambiguous placement of the CYC molecule
in the structure. The structure of the whole complex was
refined to a final Rcryst and Rfree of 22.8% and 26.7%,
respectively.
4. Overall description of the structure
The crystallized yeast QCR consists per monomer of
nine subunits with a total molecular mass of 225 kDa. The
transmembrane region is formed by 24 a-helices. A large
polar domain made up mainly by subunits COR1 and QCR2
protrudes into the matrix, whereas the catalytic domains of
subunits RIP1 and CYT1 are exposed to the intermembrane
space (Fig. 3a). CYC is bound to subunit CYT1 of monomer
B of the homodimeric QCR. There is no evidence that the
orientation of the substrate molecule is influenced by crystal
contacts. Furthermore, no steric hindrance for a CYC
molecule bound in equivalent orientation to the recognition
site of monomer A could be detected. Therefore, we con-
clude that the binding mode between the enzyme complex
and the substrate molecule is specific. The antibody frag-
ment bound to RIP1 neither interacts with CYC in the b-
orientation of the mobile extrinsic domain [1] nor in the c1-
position, which was modeled by superimposition of the
RIP1:FV18E11 portion of the structure with the c1-orientation
of the Rieske-protein in the bovine QCR structure (PDB-
entry 1BE3). The crystallographic analysis is in accordance
with activity measurements (see above) and clearly shows
that the antibody fragment does not interfere with CYC
binding.
5. Binding mode of CYC and CYT1
CYC is bound to subunit CYT1 with the two heme clefts
facing each other, thereby forming a tightly interacting and
complementary contact area (Fig. 3b). Heme c1 and heme c
are remarkably close with their pyrrole C rings pointing
towards each other. The CBC atoms of the two respective
vinyl groups are only 4.5 A˚ apart. The distance between the
two iron centers is 17.4 A˚. This is the shortest reported
distance between the redox centers of CYC and its redox
partners. The interplanar angle of the heme groups is 55j.
Fig. 2. Crystals of the QCR:CYC:FV18E11 complex. For crystallization, the
ionic strength of the protein solution was adjusted to 120 mM and rapidly
mixed with 12% PEG 4000, 20 mM Tris/HCl pH 7.5 followed by vapor
diffusion set-ups using the hanging drop technique. The two crystals grew
within three weeks at 4 jC to their final size (max. length of larger crystal
on the left f 0.9 mm). They were separated manually using microtools and
the larger crystal was used for data collection at beamline ID14EH3 (ESRF,
Grenoble) at 4 jC.
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Interestingly, this is close to the value found for the
CCP:CYC complex structure [14].
Binding of CYC to CYT1 is mainly stabilized by non-
polar interactions between amino acid residues that surround
the heme crevices and form a contact area of trapezoid shape
(Fig. 4a,b). Stabilizing interactions are found between the
following residues of CYT1 and CYC, respectively: Ala-
103 and Ala-87 (Ala-81), Phe-230 and Arg-19 (Arg-13),
Met-233 and Arg-19, Phe-230 and Thr-18 (Thr-12) as well
as Ala-168 and Val-34 (Val-28). Residues in brackets refer
to the previously used numbering system based on con-
served positions of mammalian CYC [1]. At the edge of the
heme crevice in CYT1, Ala-103 is as close as 3.4 A˚ to Ala-
Fig. 4. Binding interactions at the interface of the yeast QCR:CYC
complex. CYT1 (a) and CYC (b) are shown in surface representation
viewing the respective contact areas. The associated complex can be
visualized by an approximately 180j rotation along the horizontal line.
Residues involved in non-polar binding interactions are colored in orange,
the cation-k interaction pair is colored in green. Charged and polar residues
involved in weak electrostatic interactions are colored in blue and red. In
addition, all positively and negatively charged residues of CYC (light
green) and CYT1 (pink), respectively, are color-coded.
Fig. 3. (a) Overall structure of the complex between the redox partners CYC
(yellow) and QCR with antibody fragment FV1811 (orange) bound to the
catalytic domain of RIP1 (green). CYC binds only to one subunit CYT1 (red)
of the homodimeric complex. Protein subunits are depicted in ribbon
representation. The third catalytic subunit COB is colored in blue, QCR6 is
colored in cream. The complex is viewed parallel to the plane of the inner
membrane (orientation indicated) with the intermembrane space oriented to
the top. (b) The complementary binding interface between CYC and QCR.
Transparent surface representation of the catalytic subunits COB (blue),
CYT1 (red), and RIP1 (green) of QCR and CYC (yellow) including their
cofactors. QCR6 (cream) is shown in ribbon presentation. The first visible
residues of the mobile N-terminus of QCR6 are present close to CYC. The
figures were generated using the programsMolscript [46] and Bobscript [47].
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87 in CYC. This is the shortest distance between the
complex partners, which is critical to bring the two heme
groups in close proximity for electron transfer.
Most pronounced is the stable planar stacking interaction
between Arg-19 of CYC and Phe-230 of CYT1 in a central
position of the binding site, with the guanidino group
oriented parallel to the aromatic plane. Stacking pairs
located at molecular surfaces of proteins are known to be
involved in formation of enzyme–substrate complexes [32].
Remarkably, in the complex of yeast CCP and yeast CYC
there is also an aromatic residue (Tyr-39 of CCP) at the
complex interface near Arg-19 [14]. Interestingly, at posi-
tion 19 (13) of CYC a positive charge is highly conserved
[29] and in position 230 of CYT1 mainly aromatic residues
are present [1]. In mammalian CYC, Lys-13 has been shown
to be important for binding to QCR [17]. Cation binding to
the k face of an aromatic structure provides a relatively
strong, non-covalent binding force, the cation-k interaction
[33,34]. The stabilization between residues and atoms in van
der Waals contact is an electrostatic effect that involves the
quadrupole moment of the aromatic ring. We suggest a
conserved cation-k interaction pair involving Arg or Lys at
position 19 (yeast numbering) of CYC and position 230 of
CYT1 as general binding element at the interface of QCR:
CYC complexes.
In the past, the binding interaction of CYC and QCR was
often thought to be dominated by electrostatic forces as
supported by chemical labeling and mutagenesis studies,
which assigned conserved negatively and positively charged
residues around the heme clefts in CYT1 [20,21] and CYC
[19]. However, in the crystal structure, only two weak polar
interactions at the periphery of the recognition site are
possible between Glu-235 and Lys-92 (Lys-86) as well as
between the main chain oxygen atom of Ala-164 and Lys-85
(Fig. 4a,b). The importance of these interactions for binding
is supported by the fact that the charge of Glu-235 is
conserved in mitochondrial CYT1 [1]. Furthermore, Lys-
92 is fully conserved in CYC and its role in CYC binding
was shown by chemical labeling studies [19].
In the periphery of the described contact site of CYC and
QCR, additional pairs of often conserved residues with
opposed charges are found. They would be close enough
for indirect polar interactions (e.g. 4.8 A˚ between Lys-92 of
CYC and Asp-232 of CYT1), if water molecules are
involved. The conserved charged residues, which surround
the hydrophobic patches of CYT1 and CYC, may provide
long-range electrostatic interactions, which could direct
CYC to its recognition site on QCR as proposed for many
transient electron transfer complexes, like the ones involv-
ing plastocyanin binding to cytochrome f [16] or binding of
cytochrome c2 to the bacterial reaction center [35].
The area of the recognition site is with 880 A˚2 [1] the
smallest recognition site reported so far for protein–protein
recognition sites of low-stability complexes, which in gen-
eral are below 1600 A˚2 [36]. The small interface of the
QCR:CYC complex is well suited for a fast turnover.
Formation of transient protein complexes is required for
the CYC-mediated electron shuttling between QCR and
COX. For rapid electron transfer weak protein complexes
with short lifetime are expected.
In conclusion, binding interactions of CYC and QCR
comprise mainly non-polar interactions, a central cation-k
interaction and weak electrostatic interactions. Their con-
served and specific nature clearly indicates that the structure
resembles the physiological electron transfer complex.
6. Possible role of subunit QCR6 in binding of CYC
Previous studies on QCR from bovine heart mitochon-
dria have shown that in addition to CYT1 a second subunit
is involved in the binding of CYC [37]. This so-called hinge
protein has a highly acidic N-terminus. The homologous
subunit of yeast QCR, namely QCR6, contains 79% neg-
atively charged residues at the N-terminus, which is impor-
tant for CYC binding [21]. In the high resolution structure
of yeast QCR [10], as well as in the structures of vertebrate
QCRs [7–9] approximately 40 N-terminal residues of the
subunit cannot be located, indicating a high mobility of the
N-terminus. Interestingly, in the yeast CYC:QCR complex
[1], the visible N-terminus of QCR6 is in close vicinity to
the highly conserved lysine residues Lys-92 and Lys-93 of
CYC (Fig 3b). However, there is no direct interaction
between QCR6 and CYC visible in this structure at the
given resolution. Remarkably, the dipole moment of CYC
points with the positive side towards the N-terminus of
QCR6, which might be an indication for possible ion–
dipole interactions between QCR6 and CYC. The difference
in ionic strength dependent QCR activity between the use of
yeast or horse CYC described above might reflect the
pronounced difference in the dipole moment of CYC from
these two different sources [38]. It appears that electrostatic
components involving QCR6 are important for the orienta-
tion of CYC with respect to its binding site.
7. Direct heme-to-heme electron transfer from CYT1 to
CYC
Based on the structure of the QCR:CYC complex the
kinetics of oxidation of QCR by CYC can be estimated. For
calculating the electron transfer rate, the Dutton model for
protein electron transfer was chosen using the ET rates
package [39]. The architecture of the complex exhibits an
edge-to-edge distance of the two c-type heme groups
(C3C:C3C) of only 9.4 A˚ [1] and a packing density q of
0.65. This results in a free-energy optimized electron transfer
rate of 1.2 109 s 1. With a midpoint potential of 270 mV
for both CYT1 [40] and CYC [41] the driving force DG for
electron transfer is zero, assuming no change in redox
potentials due to binding. This, together with an estimated
reorganization energy of 0.7 eV, results in a calculated
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electron transfer rate of 8.3 106 s 1. The structure of the
complex clearly indicates electron transfer from CYT1 to
CYC by direct heme-to-heme transfer. As pointed out before,
a structural pathway through the intervening protein, via the
remarkably close distance between Ala-103 of CYT1 and
Ala-87 of CYC appears unlikely [1]. The residues are not
conserved and transfer would be considerably slower. How-
ever, the hydrophobic patches of both cytochromes do not
seem to be tightly sealed, water molecules that are not
resolved at the given resolution might be present in the close
environment of donor and acceptor and might take part in
such a structural pathway. Future studies, including structures
of the complex at higher resolution will show, whether stably
positioned water molecules are present at the interface.
For the system of bovine heart QCR with a ruthenium-
modified horse heart CYC an experimental electron transfer
rate of 6 104 s 1 has been obtained [13]. This discrepancy
between the estimated and the experimental rate might either
be caused by the bulky ruthenium-label on Lys-72, which is
positioned near the complex interface or it might indicate a
different binding mode of horse heart CYC. In conclusion,
the structural analysis of the reduction of CYC by QCR
strongly suggests a fast direct heme-to-heme electron transfer
without the contribution of amino acid residues.
8. Half-of-the-sites binding of CYC to the homodimeric
QCR
The homodimeric QCR has two identical binding sites
for CYC. Remarkably, in the reported crystal structure of the
complex, only a single CYC molecule bound to monomer B
could be located, in a binding stoichiometry termed half-of-
the-sites binding (Fig. 3a,b) [1]. This stoichiometry is
unexpected, as the substrate is present in molar surplus in
the crystallization set-ups. Furthermore, no major conforma-
tional differences between the binding sites of monomer A
and B were detected, and the crystal packing does not
restrict accessibility to the binding site of monomer A.
Thus, the question why only one CYC molecule is bound
to the homodimeric enzyme cannot be answered on the basis
of this structure. Subtle differences, which are not resolved
at the given resolution, may cause different binding proper-
ties of the two recognition sites for CYC. It cannot be
excluded that the flexible and thus unresolved N-terminus
of QCR6 regulates binding of CYC to QCR, as it was
proposed for the homologous hinge protein of bovine QCR
[37]. In yeast, deletion of QCR6 led to a 50% decrease in
QCR activity, and the authors proposed a half-of-sites
mechanism, in which QCR operates with one-half being
‘‘silent’’ upon regulatory events [42].
Each of the two operational units of the homodimeric
QCR can, in principal, perform catalysis according to the Q
cycle. It is not known whether these units function in a
parallel, sequential or independent mode. The specific bind-
ing of one CYC molecule to one monomer of QCR indicates
that QCR might be able to reduce CYC with the second
functional unit not being active, which requires a cross-talk
between the two functional units. The latter is supported by
a recent study, which demonstrated that yeast QCR shows
anti-cooperative activity [43].
Most remarkably, CYC half-of-the sites occupancy coin-
cides with differences in the two ubiquinone reduction sites
(Qi sites) of QCR. The Qi site of monomer B with CYC
bound, is occupied with a quinone molecule in an orienta-
tion known from the high resolution structure of yeast QCR
[10]. In contrast, no clear electron density was found at the
Qi site of monomer A, indicating a very low occupancy and/
or high mobility of the molecule. Furthermore, the bend
propionate A of heme bH that stabilizes the quinone ring
plane by non-polar interaction [10,11] is displaced in
monomer A supporting a different binding mode in this site.
It appears that the occupancy state of the Qi site affects
CYC binding or vice versa. A coordinated binding of both
electron acceptors for quinol oxidation, i.e. the presence of
both acceptors at the same time [1], might avoid accumu-
lation of perilous intermediates or side products of catalysis.
Coordinated binding implies long-range interactions within
the molecule. Interestingly, long-range interactions have
been observed in cytochrome c oxidase upon binding of
CYC by a resonance Raman study [44]. Communication
between low- and high-redox potential components has
been demonstrated by kinetic studies with yeast QCR and
a Qi site-specific inhibitor [45]. Coordinated binding could
be controlled by redox-induced subtle conformational
changes and long-range electrostatic interactions. Coordi-
nated binding appears to be especially important when one
functional unit of QCR is not active, irrespective of whether
this occurs in a sequential or independent mode.
Further experiments are required to analyze whether the
redox states of different QCR cofactors affect CYC binding
and how coordination of the two reduction sites and
between the two monomers are achieved. Both coordinated
binding and half-of-the sites reactivity suggest that CYC
reduction by QCR is regulated in response to the respiratory
condition.
9. Conclusions
The structure of the complex between QCR and CYC
shows a tight and specific binding interaction between CYC
and QCR, which is mediated by a small, compact contact
site dominated by non-polar forces. A central cation-k inter-
action appears to be an important and conserved feature of
CYC binding. Weak electrostatic interactions involving
charged residues in the periphery of the binding site might
be important for orientation of the complex. Size and
characteristics of the contact site are optimal for a transient
electron transfer complex. Distance and orientation of the c-
type hemes suggest rapid and direct electron transfer by
heme-to-heme contact. The highly specific and conserved
C. Hunte et al. / Biochimica et Biophysica Acta 1555 (2002) 21–28 27
interactions under optimized binding conditions, as well as
the fast electron transfer, strongly suggest that the structure
resembles the physiological electron transfer complex,
although multiple productive conformations in vivo cannot
be excluded. Half-of-the sites binding of CYC as well as its
coordinated binding with quinone indicate a specific regu-
latory mechanisms of QCR, which need to be analyzed in
future studies.
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